NTBLQ (Notable Labs) FCF Yield %: 0.00 (As of Jun. 30, 2026)


What is Notable Labs FCF Yield %?

Notable Labs NTBLQ -90.00% FCF Yield % is 0.00 as of Jun. 30, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Notable Labs's Trailing 12-Month Free Cash Flow is $-7.29 Mil, and Market Cap is $0.00 Mil. Therefore, Notable Labs's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Notable Labs's FCF Yield % or its related term are showing as below:


NTBLQ's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -9.49
* Ranked among companies with meaningful FCF Yield % only.

Notable Labs's FCF Margin % for the quarter that ended in Jun. 2024 was -185,950.00%.

Notable Labs FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Notable Labs FCF Yield % Related Terms

Notable Labs FCF Yield % Historical Data

* Premium members only.

The historical data trend for Notable Labs's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs FCF Yield % Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
0.00 0.00 -80.86

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
FCF Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 -89.39 -245.01

NTBLQ vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Notable Labs's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Notable Labs's FCF Yield % falls into.


Notable Labs FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Notable Labs's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-13.781 / 17.04402
=-80.86%

Notable Labs's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.719 * 4 / 6.0716474
=-245.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
Notable Labs (NTBLQ) has a FCF Yield % of 0.00 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Notable Labs and its competitors.
Is Notable Labs' FCF Yield % too high?
Notable Labs' current FCF Yield % is 0.00.
How does Notable Labs' FCF Yield % compare to VRTX and REGN?
Notable Labs' FCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Notable Labs and its competitors. Notable Labs's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current FCF Yield % is 0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Notable Labs Business Description

Address 320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.